A Safety Study of SGN-35C in Adults With Advanced Cancers

Conditions: Hodgkin Disease; Lymphoma, T-Cell, Peripheral; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic Interventions: Drug: SGN-35C Sponsors: Seagen Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06254495

Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials